Open access · CC-BY
via OpenAlex
Through In Vitro Gametogenesis — Young Stem Cells
Longevity Horizon · 2025 · ▲ 39 citations
Stem-cell exhaustion
Altered intercellular communication
Partial reprogramming (OSK)
Cell culture / in vitro
In vitro
Abstract
In vitro gametogenesis (IVG) represents a groundbreaking technology that opens new horizons in reproductive and regenerative medicine. Recent advancements enable the direct reprogramming of somatic cells into germline cells, bypassing the pluripotency stage, which reduces the risk of genetic abnormalities and accelerates the process. The key stages of IVG include the induction of primordial germ cell-like cells (PGCLCs), differentiation into mature gametes, and the formation of functional germ cells under controlled conditions. The primary signaling pathways involved in this process are BMP, WNT, and retinoic acid, which regulate initiation, proliferation, and meiotic entry. To accurately replicate the gonadal microenvironment, researchers employ 3D cultures, organoid systems, and microfluidic devices. Despite significant progress, the efficiency and quality of in vitro-derived gametes still fall short of their natural counterparts. Future developments in this technology hinge on optimizing differentiation protocols, leveraging single-cell technologies, integrating genome editing, and establishing international standards. Additionally, IVG holds promise for systemic rejuvenation by replacing aged stem cells with young ones derived from reprogrammed cells. Ethical and regulatory concerns remain pressing, particularly regarding artificial embryo creation and potential social inequalities. IVG has the potential to become a cornerstone technology in treating aging, extending healthy lifespan, addressing age-related diseases, and overcoming infertility.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.65649/9909a9ee
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Tqemaladze, J. (2025). Through In Vitro Gametogenesis — Young Stem Cells. <em>Longevity Horizon</em>. https://doi.org/10.65649/9909a9ee
Vancouver
Tqemaladze J. Through In Vitro Gametogenesis — Young Stem Cells. Longevity Horizon. 2025. doi:10.65649/9909a9ee.
BibTeX
@article{jaba2025Throug,
title = {Through In Vitro Gametogenesis — Young Stem Cells},
author = {Jaba Tqemaladze},
journal = {Longevity Horizon},
year = {2025},
doi = {10.65649/9909a9ee},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Conference on Computational Biology and Bioinformatics (ICCBB) 2022
Open access · OA
Research on Cell Aging Based on Reprogramming Senescent Cells by Inhibiting Pro-Inflammatory TNF/Edn1 Pathway as a Potential Treatment of Age-Related Diseases
International Immunopharmacology 2023
Citation only
Unlocking the potential of Mesenchymal stem cells in liver Fibrosis: Insights into the impact of autophagy and aging
The Indonesian Biomedical Journal 2015
Open access · CC-BY
In Search for Anti-Aging Strategy: Can We Rejuvenate Our Aging Stem Cells?
Antioxidants 2023
Open access · CC-BY
The Key Role of Mitochondrial Function in Health and Disease
Nestlé Nutrition Institute Workshop series 2015
Preprint · OA
Cellular Senescence and the Biology of Aging, Disease, and Frailty
Longevity Horizon 2025
Open access · CC-BY